bromfenac sodium
The FDA and European approvals for Bromfenac Sodium are for use one day before and two weeks following cataract surgery for the treatment of ocular inflammation and pain. It is a nonsteroidal anti-inflammatory drug.. Reference standards of Bromfenac Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => 7,7'-Bis(4-bromobenzoyl)-1H,1'H-[3,3']-biindolinylidene-2,2'-dione
[catalogue_number] => PA 02 47520
[category_ids] => ,80,100,70,
[chemical_name] =>
[weight] => 628.28
[form] => C30H16Br2N2O4
[cas] => 1798431-98-7
[pslug] => 1798431-98-7-7-7-bis-4-bromobenzoyl-1h-1h-3-3-biindolinylidene-2-2-dione-pa0247520
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
7,7'-Bis(4-bromobenzoyl)-1H,1'H-[3,3']-biindolinylidene-2,2'-dione
Catalogue No.:PA 02 47520
Molecular Formula : C30H16Br2N2O4
Molecular Weight : 628.28
